logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Amador Bioscience Announces The Completion Of $60 Million Series B+ Round Financing

Amador Bioscience Announces The Completion Of $60 Million Series B+ Round Financing

12/30/21, 10:50 AM
Money raised
$60 million
Round Type
series b
Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed 60MM USD Series B+ financing led by MSA Capital, a global private equity firm. Other participating investors include Series B Co-leads GL Ventures (venture capital arm of Hillhouse Group) and Sequoia Capital, and Series A lead VC Co-win Ventures.

Company Info

Company
Amador Bioscience
Additional Info
At Amador we provide global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.